149207-10-3

Upstream product

• 100-39-0 benzyl bromide 
• 69832-48-0 3-C-deoxy-3-C-hydroxymethyl-1,2;5,6-di-O-isopropylidene-α-D-allo-furanose 
• 582-52-5 1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 
• 85315-67-9 3-C-(benzyloxymethyl)-3-deoxy-1,2:5,6-di-O-isopropylidene-α-D-allofuranose 
• 2847-00-9 1,2:5,6-di-O-isopropylidene-α-D-hexofuran-3-ulose 
• 21665-16-7 O¹,O²;O⁵,O⁶-diisopropylidene-3-methylene-α-D-ribo-3-deoxy-hexofuranose 
• 69832-48-0 ((3aR,5S,6R,6aR)-tetrahydro-2,2-dimethyl-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)furo[2,3-d][1,3]dioxol-6-yl)methanol 
• 85315-68-0 3-C-(benzyloxymethyl)-3-deoxy-1,2-O-isopropylidene-α-D-allofuranose 

Downstream Products

• 149207-11-4 3-benzyloxymethyl-3-deoxy-1,2-isopropylidene-4-(17-tridec-1-enyl)-α-D-erythrofuranose 
• 604801-31-2 3-C-(benzyloxymethyl)-3-deoxy-1,2-O-isopropylidene-α-D-ribofuranose 
• 629613-71-4 Methanesulfonic acid (3aR,6S,6aR)-6-benzyloxymethyl-5-methanesulfonyloxymethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-ylmethyl ester 
• 629613-68-9 1-[6a-(tert-butyl-diphenyl-silanyloxymethyl)-hexahydro-furo[3,4-b]furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 629613-67-8 1-[6a-(tert-butyl-diphenyl-silanyloxymethyl)-3-hydroxy-hexahydro-furo[3,4-b]furan-2-yl]-5-methyl-1H-pyrimidine-2,4-dione 
• 175876-70-7 (3R,4S,5R)-5-<(benzoyloxy)methyl>-4-<(benzyloxy)methyl>tetrahydrofuran-3-ol 
• 175876-71-8 (3R,4S,5R)-5-<(benzoyloxy)methyl>-4-<<(TBDMS)oxy>methyl>-tetrahydrofuran-3-ol 
• 175876-72-9 (2S,3S,4R)-2-<(benzoyloxy)methyl>-3-<<(TBDMS)oxy>methyl>-4-<(methylsulfonyl)oxy>tetrahydrofuran 
• 175876-73-0 Benzoic acid (2S,3R,4S)-4-(6-amino-purin-9-yl)-3-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-2-ylmethyl ester 
• 175876-75-2 N'-{9-[(3S,4R,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-(tert-butyl-dimethyl-silanyloxymethyl)-tetrahydro-furan-3-yl]-9H-purin-6-yl}-N,N-dimethyl-formamidine 
• 377079-33-9 Toluene-4-sulfonic acid (2S,3S,4R,5R)-2,3-bis-benzyloxymethyl-4-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester 
• 377079-34-0 Toluene-4-sulfonic acid (2S,3S,4R,5R)-2,3-bis-benzyloxymethyl-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-hydroxy-tetrahydro-furan-2-ylmethyl ester 
• 377079-29-3 Acetic acid (2S,3S,4R,5R)-4-acetoxy-2,3-bis-benzyloxymethyl-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester 
• 377079-30-6 Acetic acid (2S,3S,4R,5R)-4-acetoxy-2,3-bis-benzyloxymethyl-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester 

Relevant academic research and scientific papers

Synthesis of 3′-acetamidoadenosine derivatives as potential A 3 adenosine receptor agonists

On the basis of high binding affinity of 3′-aminoadenosine derivatives 2b at the human A3 adenosine receptor (AR), 3′- acetamidoadenosine derivatives 3a-e were synthesized from 1,2:5,6-di-O- isopropylidene-D-glucose via stereoselective hydroboration as a key step. Although all synthesized compounds were totally devoid of binding affinity at the human A3AR, our results revealed that 3′-position of adenosine can only be tolerated with small size of a hydrogen bonding donor like hydroxyl or amino group in the binding site of human A3AR. Copyright Taylor & Francis Group, LLC.

Synthesis and biological evaluation of pyrimidine nucleosides fused with 3′,4′-tetrahydrofuran ring

Pyrimidine nucleosides fused with 3′,4′-tetrahydrofuran ring were synthesized, starting from 1,2;5,6-di-O-isopropylidene-D-glucose and assayed for antiviral activities. Thymine analogue 1 and its corresponding 2′-deoxy analogue 3 exhibited high cytotoxici

Synthesis and biological evaluation of thymine nucleosides fused with 3′,4′-tetrahydrofuran ring

The pyrimidine nucleosides fused with 3′,4′-tetrahydrofuran ring were successfully synthesized, starting from 1,2; 5,6-di-O-isopropylidene-D-glucose and assayed for antiviral activities against HIV-1, HIV-2, EMCV, Cox. B3 and VSV. Thymine analogue (5) and

Synthesis of novel 3′-deoxy-3′-C-hydroxymethyl nucleosides with conformationally rigid sugar moiety as potential antiviral agents

Based on the fact that the ring expanded 3′-C-hydroxymethyl analogue of oxetanocin A exhibited potent antiviral activity, two types of conformationally rigid 3′-C-hydroxymethyl derivatives in which 2′-hydroxyl group is linked to the 4′-position or to the 6′-position were synthesized starting from 1,2;5,6-di-O-isopropylidene-D-glucose, respectively.

Nucleosides and nucleotides. 147. Synthesis of DNA dodecamers containing oxetanocin A and (2R, 3R)-2-C-(adenin-9-yl)-1,4-anhydro-2,3-dideoxy-3-C-hydroxymethyl-D-arabitol

Oxetanocin A (1) and (2R,3R)-2-C-(adenin-9-yl)-1,4-anhydro-2,3-dideoxy-3-C-hydroxy-methyl-D-arabitol (2), a ring-expanded oxetanocin analogue, were incorporated into DNA dodecamers, 5′-d(CGCG1ATTCGCG)-3′ (II), 5′-d(CGCGA1TTCGCG)-3′ (III), 5′-d(CGCG2ATTCGCG)-3′ (IV), and 5′-d(CGCGA2TTCGCG)-3′ (V). Thermally induced transitions of II, III, IV, and V together with a parent dodecamer, 5-d(CGCGAATTCGCG)-3′ (I) were monitored at 260 nm in a buffer containing 0.01 M sodium phosphate (pH 7.0), 0.02 M NaCl, and 6 μM of each dodecamer. The order of Tms was 40 °C (I) > 37 °C (IV) > 36 °C (V) > 34 °C (II) > 32 °C (III). The oligonucleotide containing 2 was more resistant to snake venom phosphodiesterase than unmodified DNA dodecamer (I).

First asymmetric synthesis of (+)- and (-)-roccellaric acid and dihydroprotolichesterinic acid

Stereocontrolled syntheses of the title compounds from (R)-2,3-isopropylidene glyceraldehyde, (S)-O-THP-lactaldehyde and 1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose ('diacetone-D-glucose') are described.